Search results
FDA Authorizes Updated Novavax COVID-19 Vaccine
Verywell Health via Yahoo News· 7 months agoNovavax's updated COVID-19 vaccine is now authorized for U.S. teens and adults. The protein-based vaccine is the only immunization option that does not...
Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses
Associated Press via AOL· 8 months agoUpdated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. Doctors hope...
FDA to authorize Novavax's Covid-19 vaccine
Politico via Yahoo News· 2 years agoThe Food and Drug Administration is expected to authorize Novavax’s coronavirus vaccine for emergency use as early as Wednesday, two people with knowledge of the matter told POLITICO. The regulatory ...
Get COVID-19 booster now — or wait for new vaccine formula? We asked the experts
Detroit Free Press via Yahoo News· 2 years agoPfizer and its German-based partner BioNTech applied this week to the U.S. Food and Drug...
FDA to authorize new Covid boosters without trials in people
NBC News via Yahoo News· 2 years agoThe updated Covid vaccine boosters, a reformulated version targeting the BA.5 omicron subvariant,...
Biotech Stock Roundup: BMY's Study Update, INCY's Drug Label Expansion, MRNA News
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
Here are the 3 shots you need to get this fall — and when to get them
Raleigh News and Observer via AOL· 8 months agoWe’ve just entered flu season, which typically runs from September to March. Doctors recommend...
How Many COVID Boosters Are There?
Verywell Health via Yahoo News· 6 months agoPast doses of the COVID vaccine will not protect you against the current strains. Current available vaccines include Pfizer-BioNTech, Moderna, and...
5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good
Zacks via Yahoo Finance· 11 months agoNew drug approvals and pipeline progress are likely to help maintain momentum for the Zacks...
